EUVIMEDEUVIMED entdecken
Open Access

Reductive death is averted by a conserved de novo lipogenic switch

Fasih M Ahsan, Jen F Rotti, Armen I Yerevanian, Sinclair W Emans, Nicole L Stuhr, Jose A Aceves-Salvador, Wei Wang, Daniel J Baker, Dimitra Pouli, Owen S Skinner, Michael D Blower, Alexander A Soukas

Molecular Cell · 2026

DOI: 10.1016/j.molcel.2026.05.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Cell, 2026. Verfasst von Fasih M Ahsan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Program in Biological a…. Hauptthemen laut MEDLINE: Lipogenesis, Metformin, Caenorhabditis elegans, Biguanides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIDDK NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biguanides, including metformin, the world's most prescribed oral hypoglycemic, extend health span and lifespan in vertebrates and invertebrates. Given the widespread use and apparent safety of metformin, it is assumed that its effects are not associated with toxicity, except when in marked excess. Here, we determine that accumulation of damaging reducing equivalents is an unanticipated toxicity associated with biguanides, defense against which requires post-transcriptional protection of de novo lipogenesis. We demonstrate that biguanide treatment during impaired lipogenesis drives NADPH toxicity, leading to catastrophic elevation of NADH/GSH reducing equivalents and accelerated death across metazoans. Multiple NADPH-generating interventions require de novo lipogenesis to prevent markedly shortened survival, indicating that this defense mechanism is broadly leveraged. We propose that fatty acid biosynthesis is a tunable rheostat that can minimize biguanide-induced reductive stress while maximizing its pro-longevity outcomes and can serve as an exploitable vulnerability in reductive stress-sensitive cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipogenesisMetforminCaenorhabditis elegansBiguanidesAnimalsNADPLongevityOxidation-ReductionCaenorhabditis elegans ProteinsNADFatty AcidsGlutathionePhenforminHypoglycemic Agents

Stichwörter der Autor:innen

Caenorhabditis eleganscancerde novo lipogenesiseukaryotic initiation factor 3lifespanmRNA translationmetforminphenforminprotein synthesisreductive stress

Substanzen

MetforminNADPBiguanidesCaenorhabditis elegans ProteinsNADFatty AcidsGlutathionePhenforminHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Medicine, Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical…
  • Department of Medicine, Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.
  • Department of Medicine, Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.
  • Program in Biological and Biomedical Sciences, Division of Medical Sciences, Harvard Medical School, Boston, MA 02115, USA.
  • Department of Biochemistry and Cell Biology, Chobanian and Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
  • Department of Medicine, Diabetes Unit and Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA 02114, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Pathology, Boston…

Förderung

  • NIA NIH HHS
  • NIDDK NIH HHS
  • NIH HHS
  • National Institute on Aging
  • Office of Research Infrastructure Programs
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institutes of Health

Zitieren

APA

Ahsan, F. M., Rotti, J. F., Yerevanian, A. I., Emans, S. W., Stuhr, N. L., Aceves-Salvador, J. A., Wang, W., Baker, D. J., Pouli, D., Skinner, O. S., Blower, M. D., & Soukas, A. A. (2026). Reductive death is averted by a conserved de novo lipogenic switch. Molecular Cell. https://doi.org/10.1016/j.molcel.2026.05.011

Vancouver

Ahsan FM, Rotti JF, Yerevanian AI, Emans SW, Stuhr NL, Aceves-Salvador JA, et al. Reductive death is averted by a conserved de novo lipogenic switch. Molecular Cell. 2026. doi:10.1016/j.molcel.2026.05.011

BibTeX
@article{Ahsan2026,
  author = {Ahsan, Fasih M and Rotti, Jen F and Yerevanian, Armen I and Emans, Sinclair W and Stuhr, Nicole L and Aceves-Salvador, Jose A and Wang, Wei and Baker, Daniel J and Pouli, Dimitra and Skinner, Owen S and Blower, Michael D and Soukas, Alexander A},
  title = {Reductive death is averted by a conserved de novo lipogenic switch},
  journal = {Molecular Cell},
  year = {2026},
  doi = {10.1016/j.molcel.2026.05.011}
}
Kostenlos starten →